Ultragenyx Pharmaceutical, Inc. (RARE)
15.43
-0.14
(-0.90%)
USD |
NASDAQ |
Nov 06, 16:00
15.42
-0.01
(-0.06%)
After-Hours: 20:00
Ultragenyx Pharmaceutical Total Long Term Debt (Quarterly) : 1.186B for Sept. 30, 2026
Total Long Term Debt (Quarterly) Chart
Historical Total Long Term Debt (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2026 | 1.186B |
| June 30, 2026 | 1.202B |
| March 31, 2026 | 1.20B |
| December 31, 2025 | 1.24B |
| September 30, 2025 | 850.97M |
| June 30, 2025 | 882.91M |
| March 31, 2025 | 889.70M |
| December 31, 2024 | 899.71M |
| September 30, 2024 | 902.07M |
| June 30, 2024 | 914.82M |
| March 31, 2024 | 932.17M |
| December 31, 2023 | 922.14M |
| September 30, 2023 | 952.55M |
| June 30, 2023 | 930.45M |
| March 31, 2023 | 918.61M |
| December 31, 2022 | 895.44M |
| September 30, 2022 | 896.75M |
| June 30, 2022 | 396.48M |
| March 31, 2022 | 395.00M |
| December 31, 2021 | 383.26M |
| September 30, 2021 | 392.12M |
| June 30, 2021 | 390.20M |
| March 31, 2021 | 386.34M |
| December 31, 2020 | 375.38M |
| September 30, 2020 | 375.49M |
| Date | Value |
|---|---|
| June 30, 2020 | 362.09M |
| March 31, 2020 | 355.79M |
| December 31, 2019 | 345.13M |
| September 30, 2019 | 31.21M |
| June 30, 2019 | 32.97M |
| March 31, 2019 | 22.98M |
| December 31, 2018 | 0.00 |
| September 30, 2018 | 0.00 |
| June 30, 2018 | 0.00 |
| March 31, 2018 | 0.00 |
| December 31, 2017 | 0.00 |
| September 30, 2017 | 0.00 |
| June 30, 2017 | 0.00 |
| March 31, 2017 | 0.00 |
| December 31, 2016 | 0.00 |
| September 30, 2016 | 0.00 |
| June 30, 2016 | 0.00 |
| March 31, 2016 | 0.00 |
| December 31, 2015 | 0.00 |
| September 30, 2015 | 0.00 |
| June 30, 2015 | 0.00 |
| March 31, 2015 | 0.00 |
| December 31, 2014 | 0.00 |
| September 30, 2014 | 0.00 |
| June 30, 2014 | 0.00 |
Total Long Term Debt Definition
Represents a company's total debt maturing for more than 12 months of the reporting period.
Total Long Term Debt (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Long Term Debt (Quarterly) Benchmarks
| Ionis Pharmaceuticals, Inc. | 2.189B |
| AbbVie, Inc. | 80.90B |
| Krystal Biotech, Inc. | 6.772M |
| BridgeBio Pharma, Inc. | 3.376B |
| Alnylam Pharmaceuticals, Inc. | 2.951B |